WASHINGTON (WJZ) — An FDA advisory committee voted Friday to recommend authorizing Johnson & Johnson’s new COVID-19 vaccine.
Johnson & Johnson’s new Baltimore-made vaccine is safe and effective at fighting COVID-19, an analysis from the Food and Drug Administration found this week.
Employees of Emergent BioSolutions are working at a unique facility in southeast Baltimore where COVID-19 vaccines, including the new Johnson & Johnson vaccine, will be produced for use around the United States.
- TIMELINE: Coronavirus In Maryland, Tracking The Spread
- Latest coronavirus stories from WJZ
- Latest CDC Guidelines
The CDC said the Johnson & Johnson vaccine, also known as the Janssen vaccine, is expected to be authorized as soon as Saturday and recommended for use Sunday, CBS News reports.